Login to Your Account

Fourth time's the charm for Merck analgesic reversal agent Bridio

By Jennifer Boggs
Managing Editor

Tuesday, December 15, 2015

The FDA finally gave its nod late Tuesday afternoon to Merck & Co. Inc.'s analgesic reversal agent sugammadex, the approval coming nearly eight years after the original new drug application was submitted.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription